Arcadia Biosciences Appoints Thomas Schaefer as Class I Director
Company Announcements

Arcadia Biosciences Appoints Thomas Schaefer as Class I Director

An update from Arcadia Biosciences (RKDA) is now available.

Arcadia Biosciences, Inc. has elevated Thomas J. Schaefer to a Class I director position following Stanley Jacot’s resignation. Schaefer, who has been with Arcadia since 2020 and its president and CEO since 2022, brings a robust financial background to the role, including a past as a finance director in the food industry and an equity research analyst. His academic credentials include a BBA and an MBA from prestigious institutions, underscoring his expertise in economics and finance.

See more data about RKDA stock on TipRanks’ Stock Analysis page.

Related Articles
Ryan AdistRKDA Upcoming Earnings Report: What to Expect?
TheFlyArcadia Biosciences reports Q2 EPS 78cs vs 61c last year
Christine BrownRKDA Earnings this Week: How Will it Perform?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App